Results of a 6-month phase 3 trial using the non-benzodiazepine eszopiclone in 788 patients with chronic insomnia showed improved sleep maintenance versus placebo.

Get the latest industry news, event updates, and more from Managed healthcare Executive.

Subscribe Now!

Eszopiclone treats chronic insomnia without increasing dose

Newsletter